Tag | Content |
---|
EnhancerAtlas ID | HS041-02112 | Organism | Homo sapiens | Tissue/cell | EWS502 | Coordinate | chr1:162625820-162626560 | TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
EWSR1-FLI1 | MA0149.1 | chr1:162626362-162626380 | TCTTCCTTCCTCCCTCCT | - | 6.04 | EWSR1-FLI1 | MA0149.1 | chr1:162626342-162626360 | CTTTTCTTCCTCCCTCCC | - | 6.24 | EWSR1-FLI1 | MA0149.1 | chr1:162626346-162626364 | TCTTCCTCCCTCCCTTTC | - | 6.42 | EWSR1-FLI1 | MA0149.1 | chr1:162626378-162626396 | CTTTCCTTCCTCTTTTCC | - | 6.42 | EWSR1-FLI1 | MA0149.1 | chr1:162626382-162626400 | CCTTCCTCTTTTCCTTCC | - | 6.69 | EWSR1-FLI1 | MA0149.1 | chr1:162626370-162626388 | CCTCCCTCCTTTCCTTCC | - | 6.72 | EWSR1-FLI1 | MA0149.1 | chr1:162626350-162626368 | CCTCCCTCCCTTTCTTCC | - | 7.09 | EWSR1-FLI1 | MA0149.1 | chr1:162626366-162626384 | CCTTCCTCCCTCCTTTCC | - | 7.28 | EWSR1-FLI1 | MA0149.1 | chr1:162626354-162626372 | CCTCCCTTTCTTCCTTCC | - | 7.82 | EWSR1-FLI1 | MA0149.1 | chr1:162626358-162626376 | CCTTTCTTCCTTCCTCCC | - | 7.88 | ZNF263 | MA0528.1 | chr1:162626373-162626394 | CCCTCCTTTCCTTCCTCTTTT | - | 6.1 | ZNF263 | MA0528.1 | chr1:162626369-162626390 | TCCTCCCTCCTTTCCTTCCTC | - | 6.26 | ZNF263 | MA0528.1 | chr1:162626346-162626367 | TCTTCCTCCCTCCCTTTCTTC | - | 6.32 | ZNF263 | MA0528.1 | chr1:162626361-162626382 | TTCTTCCTTCCTCCCTCCTTT | - | 6.33 | ZNF263 | MA0528.1 | chr1:162626353-162626374 | CCCTCCCTTTCTTCCTTCCTC | - | 6.35 | ZNF263 | MA0528.1 | chr1:162626366-162626387 | CCTTCCTCCCTCCTTTCCTTC | - | 6.48 | ZNF263 | MA0528.1 | chr1:162626357-162626378 | CCCTTTCTTCCTTCCTCCCTC | - | 6.5 | ZNF263 | MA0528.1 | chr1:162626354-162626375 | CCTCCCTTTCTTCCTTCCTCC | - | 6.8 | ZNF263 | MA0528.1 | chr1:162626370-162626391 | CCTCCCTCCTTTCCTTCCTCT | - | 6.8 | ZNF263 | MA0528.1 | chr1:162626350-162626371 | CCTCCCTCCCTTTCTTCCTTC | - | 7.42 |
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
| Enhancer Sequence | ATTTCCACAT ATCAAGGTGG TCTGCTGCAG GTGAATTTTG GTCTGAATGG GACTTCTCAG 60 TTCATCCTTT GGCAGGCTAA AATCCCACTG AGGATCTAGA ACTGTAGCAA TTTCTAGATT 120 GTGTCTGAGA CCTTCCCAGC CTGGAGCTCC ATATCTCCTT CATGCCTGTG CCTCTAGCAT 180 CTAGCACAGG GTCTGACACA TGGAGGATGC TCAGCGAGAG CCCTCAGATT CAACTTAGGC 240 TTTACTGTAT TCTGCACAGC TTCTGGAATG AGTGCTGAAT GAATGAATGA GTGAGTAAAT 300 AATGTGAATG ATTATTGGGA TAAGGGTGGG GCTAAAGTGG TATTTTCTTA CATTCCCCAG 360 AAGATTTCTT CTCCCTGTCA AGATGCTTTT TGGATTATCT CTTCCTTTCT GTTTATTATC 420 TAGGGAATGC CTCGCTGCTC TTTAGCTTCC TGGTGGTAAT AATTCACTTC ATAGTTTAAT 480 GTCTTAGGTT TCCTTCTTCC CACAGATTGC CTTCAAATTT GCCTTTTCTT CCTCCCTCCC 540 TTTCTTCCTT CCTCCCTCCT TTCCTTCCTC TTTTCCTTCC TTATGATAGA CTCTTGGTAT 600 GGGGGAGTTA AGAGGTCTTA ACTTGAGCCT TCACAGTGTA TATTTTAGAA TGAATAATTC 660 ATTGCTATGC TTCACCACCA ACCAGAAATT ATTACAGGGT TTCTCTATTA CATGAGATTT 720 TTCAAACATT ATTTATCTAT 740
|
| |
|
|
|